Search Results 851-860 of 15029 for Dental zirconium

  1. Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery - Mayo Clinic

    ... oral corticosteroids; Hx of drug-induced acute tubular necrosis; Chronic renal failure or current evidence of moderate to severe renal impairment; Current ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Hematology/Oncology · Pediatric ...

  3. A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant - Mayo Clinic

    antimicrobial use (oral or parenteral) is allowed. - Participants who require treatment with moderate or strong CYP3A inducers within 14 days prior to ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Hematology/Oncology · Pediatric ...

  5. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

    Inadequate response to at least a 4-week (28 day) treatment with an oral antibiotic for the treatment of HS, or for whom oral antibiotic treatments are ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Hematology/Oncology · Pediatric ...

  7. Health Topics - Mayo Clinic News Network

    Mayo Clinic Q&A podcast: Advances in oral cancer treatment, reconstruction. Jennifer O'Hara. April 26, 2022. Cancer. Mayo Clinic Minute: Improved treatments for ...

  8. A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy - Mayo Clinic

    Patients must be able to take oral medications. Exclusion Criteria: Patient has mucinous or clear cell subtypes of epithelial ovarian cancer, carcinosarcoma ...

  9. Study of Sparsentan in Patients with Primary Focal Segmental Glomerulosclerosis - Mayo Clinic

    Examples of highly reliable contraception methods include stable oral, implanted, transdermal, or injected contraceptive hormones associated with inhibition ...

  10. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Hematology/Oncology · Pediatric ...